PKM and cancer: Pyruvate kinase M2 (PKM2) is a cancer-specific isoform that facilitates the conversion of phosphoenolpyruvate (PEP) to pyruvate, with its less efficient activity allowing glycolytic intermediates to accumulate for biosynthesis [72].